Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels
JAMA Intern Med 2023 Feb 06;[EPub Ahead of Print], E D'Andrea, DJ Wexler, SC Kim, JM Paik, E Alt, E PatornoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.